AU2002232403A1 - Del-1 and benign prostatic hyperplasia - Google Patents

Del-1 and benign prostatic hyperplasia

Info

Publication number
AU2002232403A1
AU2002232403A1 AU2002232403A AU3240302A AU2002232403A1 AU 2002232403 A1 AU2002232403 A1 AU 2002232403A1 AU 2002232403 A AU2002232403 A AU 2002232403A AU 3240302 A AU3240302 A AU 3240302A AU 2002232403 A1 AU2002232403 A1 AU 2002232403A1
Authority
AU
Australia
Prior art keywords
del
benign prostatic
prostatic hyperplasia
hyperplasia
benign
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232403A
Other languages
English (en)
Inventor
Robert H. Getzenberg
Prakash Kulkarni
William E. Munger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Ore Pharmaceuticals Inc
Original Assignee
Japan Tobacco Inc
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, Ore Pharmaceuticals Inc filed Critical Japan Tobacco Inc
Publication of AU2002232403A1 publication Critical patent/AU2002232403A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002232403A 2000-11-06 2001-11-05 Del-1 and benign prostatic hyperplasia Abandoned AU2002232403A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24567400P 2000-11-06 2000-11-06
US60/245,674 2000-11-06
PCT/US2001/042915 WO2002036826A2 (fr) 2000-11-06 2001-11-05 Gene del-1 et hyperplasie benigne de la prostate

Publications (1)

Publication Number Publication Date
AU2002232403A1 true AU2002232403A1 (en) 2002-05-15

Family

ID=22927616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232403A Abandoned AU2002232403A1 (en) 2000-11-06 2001-11-05 Del-1 and benign prostatic hyperplasia

Country Status (2)

Country Link
AU (1) AU2002232403A1 (fr)
WO (1) WO2002036826A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001093A1 (fr) * 2003-06-30 2005-01-06 Nihon University Proteine pouvant se deposer sur une matrice extracellulaire
JP5791022B2 (ja) 2010-12-13 2015-10-07 学校法人日本大学 細胞遊走調節剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874562A (en) * 1995-06-07 1999-02-23 Progenitor, Inc. Nucleic acid encoding developmentally-regulated endothelial cell locus-1

Also Published As

Publication number Publication date
WO2002036826A2 (fr) 2002-05-10
WO2002036826A3 (fr) 2003-11-20

Similar Documents

Publication Publication Date Title
AU2001247770A1 (en) Biased rotatable combdrive devices and methods
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001237996A1 (en) Thermally and chemically treating cells
AU2001286547A1 (en) Support and related shelf
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
IL141235A0 (en) Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2002211717A1 (en) Stresscopins and their uses
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU4843500A (en) Destructible surfactants and uses thereof
EP0855910A4 (fr) Conjugues utiles pour traiter l'adenome prostatique benin
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
HK1030776A1 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU2002224876A1 (en) Isolated luciferases and the use thereof
AU2002232403A1 (en) Del-1 and benign prostatic hyperplasia
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2001292952A1 (en) Selective inactivation and copy-protection
AU6570998A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis